Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Presumed Guilty: HHS Exclusion Guidance Shifts Burden Of Proof To Corporate Officers

Executive Summary

More company officials may be excluded from government health care programs as the Health and Human Services’ Office of Inspector General is going to presume individuals should be excluded if there is evidence they knew or should have known of misconduct.

You may also be interested in...



Ranbaxy Fraud Settlement Emphasizes Guilty Pleas, Downplays Exclusion

Although pharmaceutical company settlements in the millions of dollars now seem customary, a guilty plea to seven felonies could signal aggressive government pursuit of manufacturing and data integrity concerns.

HHS Office of Inspector General Drops Challenge To Forest CEO Solomon

Amid drama from dissident investor Carl Icahn, Forest is relieved of the fear that the federal OIG could bar its CEO from contracting with government health care programs.

OIG Exclusion Power Complicating Consent Decree Negotiations

Companies are having a tougher time negotiating corporate integrity agreements since HHS' Office of Inspector General has intensified its efforts to exclude individuals from federal health care programs.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS052759

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel